Immunotherapy for triple-negative breast cancer: A molecular insight into the microenvironment, treatment, and resistance
{{output}}
Clinicians have very limited options to treat triple-negative breast cancer (TNBC) due to the lack of effective targeted drugs. Recently, the findings of the mechanism underlying tumor-intrinsic immune escape have fueled a wave of studies into immunotherapy in... ...
